Funded Biotechnology Startups in Bangalore
Across the 14 most recent Bangalore biotechnology rounds shown, MedGenome’s $50M (2022-08-30) is the largest disclosed amount and sits well above the next-…
Across the 14 most recent Bangalore biotechnology rounds shown, MedGenome’s $50M (2022-08-30) is the largest disclosed amount and sits well above the next-largest disclosed rounds (String Bio at $20M on 2022-07-11 and PlasmaGen Biosciences at $17M on 2025-12-22). A second pattern is the concentration in time: five of the 14 rounds fall between 2022-07-11 and 2022-11-09 (String Bio $20M on 2022-07-11, Sea6 Energy $10M on 2022-08-17, MedGenome $50M on 2022-08-30, Phyx44 Labs $1M on 2022-11-09, and one $10–20M+? no), and the most recent date in the list is 2026-06-11 (Biodimension Technology, $840K).
Stage/label coverage also skews toward not-explicitly-categorized rounds: five entries are marked “Series Unknown” (Biodimension Technology 2026-06-11 $840K; PlasmaGen Biosciences 2025-12-22 $17M; BrainSightAI 2023-07-10 $120K; and MedGenome 2022-08-30 $50M; plus the unlabeled “Series Unknown” entry BUGWORKS Research 2024-03-08 $7M has a blank label), and one row is explicitly “undisclosed” (NKure Therapeutics, 2023-04-26).
Most recent rounds
14 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Bangalore biotech list, and how separated is it from the rest?
MedGenome’s disclosed $50M on 2022-08-30 is the largest amount shown, noticeably above the next-largest disclosed rounds: String Bio’s $20M (2022-07-11) and PlasmaGen Biosciences’ $17M (2025-12-22). Most other disclosed amounts cluster below those levels, including $10M (Sea6 Energy on 2022-08-17) and single-digit rounds like BrainSightAI’s $5M (2025-01-08).
Do multiple rounds cluster in a narrow time window in Bangalore, or are they spread out evenly?
There’s a clear 2022 concentration: String Bio ($20M, 2022-07-11), Sea6 Energy ($10M, 2022-08-17), MedGenome ($50M, 2022-08-30), and Phyx44 Labs ($1M, 2022-11-09) fall within about four months. Outside that window, the list extends back to 2021-05-11 (Artivatic.ai, $1M) and runs up to 2026-06-11 (Biodimension Technology, $840K).
How are stages labeled, and is “Series Unknown” a dominant share of the rows?
“Series Unknown” appears on four rows with explicit amounts: Biodimension Technology ($840K, 2026-06-11), PlasmaGen Biosciences ($17M, 2025-12-22), BrainSightAI ($120K, 2023-07-10), and MedGenome ($50M, 2022-08-30). Separately, BUGWORKS Research on 2024-03-08 shows a blank series label (with $7M), and NKure Therapeutics on 2023-04-26 is explicitly “undisclosed”.
Which named entities show repeat appearances, suggesting follow-on fundraising visibility?
BrainSightAI appears twice in Bangalore with different disclosed amounts: $120K on 2023-07-10 (Series Unknown) and $5M on 2025-01-08 (Seed). That’s a notable jump in disclosed round size across the two dated entries.
Are there notable outliers in round size on the high or low end?
On the low end, the smallest disclosed amount is $120K for BrainSightAI on 2023-07-10, with another small disclosed round at $840K for Biodimension Technology on 2026-06-11. The high-end outlier is MedGenome’s $50M (2022-08-30), which sits far above the next-largest disclosed rounds of $20M (String Bio, 2022-07-11) and $17M (PlasmaGen Biosciences, 2025-12-22).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.